Accendra Health (NYSE:ACH) Stock Moved Up to Hold by Zacks Research

Accendra Health (NYSE:ACH) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Tuesday, Zacks reports.

A number of other equities analysts also recently weighed in on the company. Citigroup downgraded Accendra Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $4.50 to $1.50 in a research note on Monday, August 10th. Robert W. Baird downgraded Accendra Health from an “outperform” rating to a “neutral” rating and set a $1.50 price target for the company. in a research report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Accendra Health in a report on Tuesday. Finally, UBS Group dropped their price target on Accendra Health from $4.50 to $1.50 and set a “neutral” rating on the stock in a report on Thursday, August 13th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Accendra Health has a consensus rating of “Reduce” and an average price target of $1.50.

Accendra Health Stock Performance

Accendra Health stock opened at $0.28 on Tuesday. Accendra Health has a fifty-two week low of $0.19 and a fifty-two week high of $4.69. The stock has a market cap of $21.17 million, a PE ratio of 1.23 and a beta of 1.60. The firm’s 50-day simple moving average is $0.66 and its 200 day simple moving average is $2.14.

Accendra Health (NYSE:ACH) last issued its quarterly earnings data on Monday, August 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.06). The firm had revenue of $613.23 million during the quarter. Accendra Health had a negative return on equity of 4.02% and a negative net margin of 11.41%. As a group, analysts predict that Accendra Health will post -0.03 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Walleye Capital LLC bought a new position in Accendra Health in the 1st quarter worth approximately $27,000. Hsbc Holdings PLC bought a new stake in Accendra Health during the 1st quarter valued at $34,000. Corient Private Wealth LP bought a new stake in Accendra Health during the 2nd quarter valued at $40,000. Abel Hall LLC bought a new stake in Accendra Health during the 1st quarter valued at $44,000. Finally, Keybank National Association OH purchased a new stake in shares of Accendra Health during the first quarter worth $46,000.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.